195 related articles for article (PubMed ID: 34193701)
1. [Loss of homeostatic microglia in rare neurological disorders: implications for cell transplantation].
Ikeuchi T; Fitrah YA; Shu B
Nihon Yakurigaku Zasshi; 2021; 156(4):225-229. PubMed ID: 34193701
[TBL] [Abstract][Full Text] [Related]
2. Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
Li X; Hu B; Guan X; Wang Z; Zhou Y; Sun H; Zhang X; Li Y; Huang X; Zhao Y; Wang X; Xu H; Zhang YW; Wang Z; Zheng H
J Neuroinflammation; 2023 May; 20(1):134. PubMed ID: 37259140
[TBL] [Abstract][Full Text] [Related]
3. Microglial reduction of colony stimulating factor-1 receptor expression is sufficient to confer adult onset leukodystrophy.
Biundo F; Chitu V; Shlager GGL; Park ES; Gulinello ME; Saha K; Ketchum HC; Fernandes C; Gökhan Ş; Mehler MF; Stanley ER
Glia; 2021 Mar; 69(3):779-791. PubMed ID: 33079443
[TBL] [Abstract][Full Text] [Related]
4. Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy.
Han J; Sarlus H; Wszolek ZK; Karrenbauer VD; Harris RA
Acta Neuropathol Commun; 2020 Dec; 8(1):217. PubMed ID: 33287883
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.
Gelfand JM; Greenfield AL; Barkovich M; Mendelsohn BA; Van Haren K; Hess CP; Mannis GN
Brain; 2020 Feb; 143(2):503-511. PubMed ID: 31840744
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).
Chitu V; Gokhan S; Gulinello M; Branch CA; Patil M; Basu R; Stoddart C; Mehler MF; Stanley ER
Neurobiol Dis; 2015 Feb; 74():219-28. PubMed ID: 25497733
[TBL] [Abstract][Full Text] [Related]
7. Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy.
Kempthorne L; Yoon H; Madore C; Smith S; Wszolek ZK; Rademakers R; Kim J; Butovsky O; Dickson DW
Acta Neuropathol Commun; 2020 May; 8(1):72. PubMed ID: 32430064
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
Lynch DS; Zhang WJ; Lakshmanan R; Kinsella JA; Uzun GA; Karbay M; Tüfekçioglu Z; Hanagasi H; Burke G; Foulds N; Hammans SR; Bhattacharjee A; Wilson H; Adams M; Walker M; Nicoll JA; Chataway J; Fox N; Davagnanam I; Phadke R; Houlden H
JAMA Neurol; 2016 Dec; 73(12):1433-1439. PubMed ID: 27749956
[TBL] [Abstract][Full Text] [Related]
9. Dominant-acting CSF1R variants cause microglial depletion and altered astrocytic phenotype in zebrafish and adult-onset leukodystrophy.
Berdowski WM; van der Linde HC; Breur M; Oosterhof N; Beerepoot S; Sanderson L; Wijnands LI; de Jong P; Tsai-Meu-Chong E; de Valk W; de Witte M; van IJcken WFJ; Demmers J; van der Knaap MS; Bugiani M; Wolf NI; van Ham TJ
Acta Neuropathol; 2022 Aug; 144(2):211-239. PubMed ID: 35713703
[TBL] [Abstract][Full Text] [Related]
10. Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia.
Oosterhof N; Chang IJ; Karimiani EG; Kuil LE; Jensen DM; Daza R; Young E; Astle L; van der Linde HC; Shivaram GM; Demmers J; Latimer CS; Keene CD; Loter E; Maroofian R; van Ham TJ; Hevner RF; Bennett JT
Am J Hum Genet; 2019 May; 104(5):936-947. PubMed ID: 30982608
[TBL] [Abstract][Full Text] [Related]
11. Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo.
Oosterhof N; Kuil LE; van der Linde HC; Burm SM; Berdowski W; van Ijcken WFJ; van Swieten JC; Hol EM; Verheijen MHG; van Ham TJ
Cell Rep; 2018 Jul; 24(5):1203-1217.e6. PubMed ID: 30067976
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation.
Konno T; Yoshida K; Mizuta I; Mizuno T; Kawarai T; Tada M; Nozaki H; Ikeda SI; Onodera O; Wszolek ZK; Ikeuchi T
Eur J Neurol; 2018 Jan; 25(1):142-147. PubMed ID: 28921817
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy.
Chadarevian JP; Hasselmann J; Lahian A; Capocchi JK; Escobar A; Lim TE; Le L; Tu C; Nguyen J; Kiani Shabestari S; Carlen-Jones W; Gandhi S; Bu G; Hume DA; Pridans C; Wszolek ZK; Spitale RC; Davtyan H; Blurton-Jones M
Neuron; 2024 Jun; ():. PubMed ID: 38897209
[TBL] [Abstract][Full Text] [Related]
14. An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders.
Dorion MF; Casas D; Shlaifer I; Yaqubi M; Fleming P; Karpilovsky N; Chen CX; Nicouleau M; Piscopo VEC; MacDougall EJ; Alluli A; Goldsmith TM; Schneider A; Dorion S; Aprahamian N; MacDonald A; Thomas RA; Dudley RWR; Hall JA; Fon EA; Antel JP; Stratton JA; Durcan TM; La Piana R; Healy LM
Mol Neurodegener; 2024 Apr; 19(1):31. PubMed ID: 38576039
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Miura T; Mezaki N; Konno T; Iwasaki A; Hara N; Miura M; Funayama M; Unai Y; Tashiro Y; Okita K; Kihara T; Ito N; Kanatsuka Y; Jones DT; Hara N; Ishiguro T; Tokutake T; Kasuga K; Nozaki H; Dickson DW; Onodera O; Wszolek ZK; Ikeuchi T
J Neurol; 2018 Oct; 265(10):2415-2424. PubMed ID: 30136118
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.
Konno T; Yoshida K; Mizuno T; Kawarai T; Tada M; Nozaki H; Ikeda SI; Nishizawa M; Onodera O; Wszolek ZK; Ikeuchi T
Eur J Neurol; 2017 Jan; 24(1):37-45. PubMed ID: 27680516
[TBL] [Abstract][Full Text] [Related]
17. A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling.
Stables J; Green EK; Sehgal A; Patkar OL; Keshvari S; Taylor I; Ashcroft ME; Grabert K; Wollscheid-Lengeling E; Szymkowiak S; McColl BW; Adamson A; Humphreys NE; Mueller W; Starobova H; Vetter I; Shabestari SK; Blurton-Jones MM; Summers KM; Irvine KM; Pridans C; Hume DA
Development; 2022 Apr; 149(8):. PubMed ID: 35333324
[TBL] [Abstract][Full Text] [Related]
18. Partial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities.
Konno T; Miura T; Harriott AM; Mezaki N; Edwards ES; Rademakers R; Ross OA; Meschia JF; Ikeuchi T; Wszolek ZK
Eur J Neurol; 2018 Jun; 25(6):875-881. PubMed ID: 29509319
[TBL] [Abstract][Full Text] [Related]
19. Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders.
Hu B; Duan S; Wang Z; Li X; Zhou Y; Zhang X; Zhang YW; Xu H; Zheng H
Front Aging Neurosci; 2021; 13():789834. PubMed ID: 34867307
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Basic Research for CSF1R-Microglial Encephalopathy.
Wang YL; Wang FZ; Li R; Jiang J; Liu X; Xu J
Front Aging Neurosci; 2021; 13():792840. PubMed ID: 34955818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]